Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
about
The potential role of amyloid beta in the pathogenesis of age-related macular degeneration.A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8The relationship between anisometropia and amblyopiaThe LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samplesThe Tehran Eye Study: research design and eye examination protocolFive-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye StudyEmerging therapies for neovascular age-related macular degeneration: state of the artDrusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degenerationA survey on computer aided diagnosis for ocular diseasesArea deprivation, individual socioeconomic status and low vision in the EPIC-Norfolk Eye StudyDissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degenerationThe therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studiesDesign, methodology and baseline data of a school-based cohort study in Central China: the Anyang Childhood Eye Study.New treatments in age-related macular degeneration.Validity of carbohydrate, glycaemic index and glycaemic load data obtained using a semi-quantitative food-frequency questionnaire.The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.Socioeconomic status and incident cataract surgery: the Blue Mountains Eye Study.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Treatment of age-related macular degeneration.A review of drug options in age-related macular degeneration therapy and potential new agents.Macular oedema is not predicted by perifoveal single blot haemorrhages.Rationale, design, methodology, and baseline data of a population-based study in rural China: the Handan Eye Study.Visual outcomes 12 months after phacoemulsification cataract surgery in patients with diabetes.Refractive ocular conditions and reasons for spectacles renewal in a resource-limited economy.Cataract Surgery and Visual Acuity in Elderly Japanese: Results of Fujiwara-kyo Eye StudyCommon eye diseases in older adults of southern Germany: results from the KORA-Age studyThe role of vision in academic school performanceTargeted Delivery of FLT-Morpholino Using Cyclic RGD PeptidePrevalence and causes of low vision and blindness in an urban population: The Chennai Glaucoma Study.Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study.Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.Medical review licensing outcomes in drivers with visual field loss in Victoria, Australia.Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.Combined influence of poor health behaviours on the prevalence and 15-year incidence of age-related macular degeneration.Disparity in prevalence of self-reported visual impairment in older adults among U.S. race-ethnic subgroups.Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samplesIs renal function associated with early age-related macular degeneration?Visual acuity and associated factors. The Central India Eye and Medical Study.Characteristics of 681 low vision patients in Korea.Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.
P2860
Q24532130-DD4BBFBA-117C-433D-874F-8DC2DE59C858Q24544001-40A517A3-8D5E-4A0A-AE26-1D12627630DDQ24621632-DBE18D2F-D3C5-4C61-96BE-F35F4D57CE7DQ24678569-4D21E36E-3526-426F-9EE7-59A5F22A5FEDQ24792500-AFCBC9FD-6756-4C12-A33C-0386A406D14DQ28191911-C0889855-DCBC-4EA2-997C-A765F49E0548Q28253918-0EBE9B16-DFE5-46C2-9936-575CE6CD4A66Q28590177-F102B07F-A6A1-4209-B5A5-E08F53E9FFF8Q28655780-BC6FA31C-169F-4847-AE22-EA3F632CFD08Q28655947-0AE213E4-5237-4022-8543-47D3604EFD65Q28769548-156A1C4F-3570-431B-B76E-83AFD82F002FQ30578074-C4904BAA-8A16-4E25-B776-98E998A8C4F9Q30684220-2A6C0225-7FEB-4E06-BC48-D473DF39DA1DQ31004243-9B5CE468-EF5F-47FB-A5F0-65A2CF6A61AAQ31134078-8BA2EE14-5AAA-4C72-8C48-36BB1C10E280Q33179930-1852833D-AE39-4CBD-9181-60F68660A4CEQ33183699-C3C6642C-276C-431E-B0DC-D971E9E9FFFAQ33212693-C993B470-2F5F-4B41-937B-D21E1E025DD5Q33226171-B6F2657B-3A0E-4524-A4DC-E701CD2D84DDQ33263803-580A1856-9501-4105-B0CD-99209B5E22ABQ33315152-143C2ADB-2CFB-486D-91B6-4EA1F370851BQ33427961-D14F02F1-9329-4DA5-9C8A-2AF50409362DQ33531896-76E95F70-2A04-42BB-B834-D531788F98DBQ33575230-FC73D1FA-344E-4CF7-A40C-2DC23D635C72Q33580568-B7793CC5-4CCE-4C61-A339-B4F2E9E4B5EFQ33605144-E97E5529-A57A-40A4-B51A-56930EED63A1Q33698056-5B13BF0B-8E33-40F9-94F8-AD2ABABE08E4Q33727486-0A90C1A4-A434-4810-B6AE-EA404BBB96BDQ33780710-D482C46C-ECEA-41DC-8659-D6398D26C4D5Q33796309-EB06D852-3510-42B0-8EFE-AF58AE1C365EQ33812061-BFAEFDF7-A87C-4854-A14B-CF55C15AC75CQ33820462-8AA67AD0-2052-4C06-A2A1-5EAD30093E8AQ33844950-31E4C3C9-1341-41F6-93F6-93D0DC73699EQ33849096-7E3C1004-AF9D-4976-9AF0-A3AE2A538D57Q33855212-2706DD77-ADBB-4BC5-8999-9C651ACC0D8AQ33950814-B10BE657-E8FC-4543-B833-C3E501F3EFAFQ33953345-AD0986E7-E8E0-4B56-9651-54CE3A262D50Q33987826-B4DA62C7-1517-411F-9EDD-3FDFCBDEFDAEQ34014816-FAB860DE-E703-40C9-83C8-23DE43B4BACBQ34055052-A710E903-DF0E-4F7A-92FA-8A1FB8007B40
P2860
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@en
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@nl
type
label
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@en
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@nl
prefLabel
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@en
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@nl
P2093
P1433
P1476
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.
@en
P2093
P304
P356
10.1016/S0161-6420(96)30684-2
P577
1996-03-01T00:00:00Z